In House HSV PCR, Process Improvement and Cost Effectiveness Analysis

In House HSV PCR, Process Improvement and Cost Effectiveness Analysis

Herpes Simples Virus (HSV) is an etiologic agent of serious central nervous system (CNS) infections in both adults and children. HSV encephalitis has a worldwide incidence of about 500,000 persons per year with an overall mortality rate of 11-19 percent with treatment. Maternal HSV infection may res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Carr,Nicholas R, Weber,Zachary J, Sutter,Deena E
Format: Report
Sprache:eng
Schlagworte:
CNS(CENTRAL NERVOUS SYSTEM)
COST ANALYSIS
COST EFFECTIVENESS
DELIVERY OF HEALTH CARE
DRUG THERAPY
ENCEPHALITIS
Herpes simplex virus
HOSPITALIZATIONS
HSV(HERPES SIMPLEX VIRUS)
INFANTS
Medicine and Medical Research
Microbiology
PCR(Polymerase chain reaction)
PEDIATRICS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Herpes Simples Virus (HSV) is an etiologic agent of serious central nervous system (CNS) infections in both adults and children. HSV encephalitis has a worldwide incidence of about 500,000 persons per year with an overall mortality rate of 11-19 percent with treatment. Maternal HSV infection may result in neonatal disease, to include disseminated skin eye and mucous membrane (SEM) and CNS infection. Neonatal HSV infections occur approximately in 1 in 3000 to 20,000 lives births with 1500 cases reported annually with 29% mortality with aggressive treatment. American Academy of Pediatrics (AAP) National Conference and Exhibition, , 15 Sep 2017, 19 Sep 2017,